Page last updated: 2024-12-05
4-methylcyclohexanol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-methylcyclohexanol: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11524 |
SCHEMBL ID | 441286 |
SCHEMBL ID | 11799 |
SCHEMBL ID | 181159 |
SCHEMBL ID | 178952 |
SCHEMBL ID | 7909834 |
MeSH ID | M0109868 |
Synonyms (97)
Synonym |
---|
bdbm36145 |
bdbm36193 |
589-91-3 |
1-methyl-4-cyclohexanol |
nsc3714 |
4-methylcyclohexanol |
nsc-3714 |
cyclohexanol, 4-methyl- |
methyl cyclohexanol |
cyclohexanol, 4-methyl-, cis- |
cis-4-methylcyclohexanol |
trans-4-methylcyclohexanol |
cyclohexanol, 4-methyl-, trans- |
p-methylcyclohexanol |
trans-4-methylcyclohexanol, 97% |
cis-4-methylcyclohexanol, 98% |
4-methylcyclohexan-1-ol |
M0196 |
M0353 |
4-methylhexalin |
7731-29-5 |
7731-28-4 |
M0354 |
AKOS000119784 |
A832098 |
A839037 |
4-methyl-1-cyclohexanol |
4-methyl-cyclohexan-1-ol |
unii-juw70559wv |
einecs 231-790-7 |
unii-zlj21o6wvr |
juw70559wv , |
4-methylcyclohexanol, trans- |
einecs 231-789-1 |
zlj21o6wvr , |
4-methylcyclohexanol, cis- |
hexahydro-p-cresol |
nsc 3714 |
einecs 209-664-8 |
unii-1uk9w4x7h9 |
1uk9w4x7h9 , |
ai3-01169 |
FT-0636583 |
FT-0619074 |
FT-0636584 |
AKOS017343697 |
AKOS025295736 |
cis-4-methylcyclohexanol98% |
SCHEMBL441286 |
trans-4-methyl-cyclohexanol |
trans-4-methylcyclohexan-1-ol |
cis-4-methyl-cyclohexanol |
SCHEMBL11799 |
SCHEMBL181159 |
SCHEMBL178952 |
SCHEMBL7909834 |
4-methyl cyclohexanol, cis- |
4-methyl cyclohexanol, trans- |
4-methylcyclohexanol, (e)- |
4-methylcyclohexanol,c&t |
4-methylcyclohexanol cis+trans |
4-methylcyclohexanol, (z)- |
1-hydroxy-4-methylcyclohexane |
DTXSID0060434 |
Q-200498 |
acidred13 |
ethyl2,6-dichloro-5-fluoropyridine-3-carboxylate |
trans 4-methyl cyclohexanol |
F8880-5214 |
mfcd00064171 |
4-methylcyclohexanol, cis + trans, 98% |
mfcd00001449 |
mfcd00064170 |
4-methylcyclohexanol, purum, cis+trans, >=98.0% (gc) |
AS-60626 |
(1r,4r)-4-methylcyclohexan-1-ol |
CS-0059254 |
4-methylcyclohexyl alcohol |
SY043391 |
CS-0180937 |
CS-0180938 |
Q2233075 |
4-chloromercuribenzoicacid |
AM9714 |
(1s,4s)-4-methylcyclohexanol |
(1r,4r)-4-methylcyclohexanol |
D73186 |
D91323 |
A914444 |
SB66832 |
4-methylcyclohexanol,mixture of cis and trans |
SB84127 |
?4-methylcyclohexanol |
EN300-19924 |
DTXSID301032962 |
DTXSID701032964 |
Z104476106 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (12)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 44.08
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (44.08) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |